Erratum: Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line (Cardiovascular Toxicology DOI: 10.1007/s12012-011-9111-5);Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line

Cardiovascular Toxicology

Volumn 11, Issue 3, 2011, Pages 191-203

  Branco, Ana F ^a   Pereira, Sandro L ^a   Moreira, Ana C ^a   Holy, Jon ^b   Sardão, Vilma A ^a   Oliveira, Paulo J ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cell differentiation; H9c2 cell line; Isoproterenol; Toxicology

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CALCINEURIN; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; TROPONIN T; VOLTAGE DEPENDENT ANION CHANNEL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL ADHESION; CELL DIFFERENTIATION; CELL LOSS; CELL MEMBRANE DEPOLARIZATION; CELL STRUCTURE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG CYTOTOXICITY; EMBRYO; GROWTH INHIBITION; HEART DEVELOPMENT; MYOBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CONTENT; RAT; UPREGULATION;

EID: 80054914028     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-011-9131-1     Document Type: Erratum

References (61)

1. Limana, F., Zacheo, A., Mocini, D., Mangoni, A., Borsellino, G., Diamantini, A., et al. (2007). Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circulation Research, 101, 1255-1265. (Pubitemid 350294642)
2. Hescheler, J., Meyer, R., Plant, S., Krautwurst, D., Rosenthal, W., & Schultz, G. (1991). Morphological, biochemical, and electro-physiological characterization of a clonal cell (H9c2) line from rat heart. Circulation Research, 69, 1476-1486.
3. Kimes, B. W., & Brandt, B. L. (1976). Properties of a clonal muscle cell line from rat heart. Experimental Cell Research, 98, 367-381.
4. Schopf, G., Rumpold, H., & Muller, M. M. (1986). Alterations of purine salvage pathways during differentiation of rat heart myoblasts towards myocytes. Biochimica et Biophysica Acta, 884, 319-325. (Pubitemid 17188776)
5. Hammes, A., Oberdorf, S., Strehler, E. E., Stauffer, T., Carafoli, E., Vetter, H., et al. (1994). Differentiation-specific isoform mRNA expression of the calmodulin-dependent plasma membrane Ca(2?)-ATPase. FASEB Journal, 8, 428-435.
6. Hunter, A. L., Zhang, J., Chen, S. C., Si, X., Wong, B., Ekhterae, D., et al. (2007). Apoptosis repressor with caspase recruitment domain (ARC) inhibits myogenic differentiation. FEBS Letter, 581, 879-884.
7. Bregant, E., Renzone, G., Lonigro, R., Passon, N., Di Loreto, C., Pandolfi, M., et al. (2009). Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation. Molecular and Cellular Biochemistry, 327, 145-152.
8. Menard, C., Pupier, S., Mornet, D., Kitzmann, M., Nargeot, J., & Lory, P. (1999). Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. Journal of Biological Chemistry, 274, 29063-29070.
9. Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R., & Wallace, K. B. (2007). Vital imaging of H9c2 myoblasts exposed to tert- butylhydroperoxide-Characterization of morphological features of cell death. BMC Cell Biology, 8, 11.
10. Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R., & Wallace, K. B. (2009). Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts. Cancer Chemotherapy and Pharmacology, 64, 811-827.
11. Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R., & Wallace, K. B. (2009). Morphological alterations induced by doxorubicin on H9c2 myoblasts: Nuclear, mitochondrial, and cytoskeletal targets. Cell Biology and Toxicology, 25, 227-243.
12. Lund, K. C., & Wallace, K. B. (2004). Direct effects of nucleo-side reverse transcriptase inhibitors on rat cardiac mitochondrial bioenergetics. Mitochondrion, 4, 193-202. (Pubitemid 39549809)
13. Saito, S., Hiroi, Y., Zou, Y., Aikawa, R., Toko, H., Shibasaki, F., et al. (2000). beta-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. Journal of Biological Chemistry, 275, 34528-34533.
14. Shizukuda, Y., & Buttrick, P. M. (2002). Subtype specific roles of beta-adrenergic receptors in apoptosis of adult rat ventricular myocytes. Journal of Molecular and Cellular Cardiology, 34, 823-831. (Pubitemid 35205184)
15. Dangel, V., Giray, J., Ratge, D., & Wisser, H. (1996). Regulation of beta-adrenoceptor density and mRNA levels in the rat heart cell-line H9c2. Biochemical Journal, 317(Pt 3), 925-931. (Pubitemid 26308272)
16. Colucci, W. S., Sawyer, D. B., Singh, K., & Communal, C. (2000). Adrenergic overload and apoptosis in heart failure: Implications for therapy. Journal of Cardiac Failure, 6, 1-7. (Pubitemid 30439432)
17. Singh, K., Communal, C., Sawyer, D. B., & Colucci, W. S. (2000). Adrenergic regulation of myocardial apoptosis. Cardiovascular Research, 45, 713-719. (Pubitemid 30047138)
18. Goldspink, D. F., Burniston, J. G., & Tan, L. B. (2003). Car-diomyocyte death and the ageing and failing heart. Experimental Physiology, 88, 447-458. (Pubitemid 36626392)
19. Houghton, P., Fang, R., Techatanawat, I., Steventon, G., Hylands, P. J., & Lee, C. C. (2007). The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. Methods, 42, 377-387. (Pubitemid 46860387)
20. Pereira, G. C., Branco, A. F., Matos, J. A., Pereira, S. L., Parke, D., Perkins, E. L., et al. (2007). Mitochondrially targeted effects of berberine [Natural Yellow 18,5,6-dihydro-9, 10-dim-ethoxybenzo(g)-1,3-benzodioxolo(5, 6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions. Journal of Pharmacology and Experimental Therapeutics, 323, 636-649. (Pubitemid 350005145)
21. Serafim, T. L., Oliveira, P. J., Sardao, V. A., Perkins, E., Parke, D., & Holy,J.(2008). Different concentrations ofberberine resultindistinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemotherapy and Pharmacology, 61, 1007-1018. (Pubitemid 351423129)
22. Kageyama, K., Ihara, Y., Goto, S., Urata, Y., Toda, G., Yano, K., et al. (2002). Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. Journal of Biological Chemistry, 277, 19255-19264. (Pubitemid 34967429)
23. Brostrom, M. A., Reilly, B. A., Wilson, F. J., & Brostrom, C. O. (2000). Vasopressin-induced hypertrophy in H9c2 heart-derived myocytes. International Journal of Biochemistry and Cell Biology, 32, 993-1006.
24. Hou, Q., & Hsu, Y. T. (2005). Bax translocates from cytosol to mitochondria in cardiac cells during apoptosis: development of a GFP-Bax-stable H9c2 cell line for apoptosis analysis. American Journal of Physiology. Heart and Circulatory Physiology, 289, H477-H487. (Pubitemid 40934135)
25. Kim, J. Y., Lee, J. J., & Kim, K. S. (2003). Acetyl-CoA car-boxylase beta expression mediated by MyoD and muscle regulatory factor 4 is differentially affected by retinoic acid receptor and retinoid X receptor. Exp Mol Med, 35, 23-29.
26. Kuzmenkin, A., Liang, H., Xu, G., Pfannkuche, K., Eichhorn, H., Fatima, A., et al. (2009). Functional characterization of cardio-myocytes derived from murine induced pluripotent stem cells in vitro. FASEB Journal, 23, 4168-4180.
27. Decker, R.S., Rines,A. K., Nakamura, S., Naik,T. J., Wassertsrom, J. A., & Ardehali, H. (2009). Phosphorylation of contractile proteins in response to alpha-and beta-adrenergic stimulation in neonatal cardiomyocytes. Translational Research, 155, 27-34.
28. Zhou, B., Wu, L. J., Tashiro, S., Onodera, S., Uchiumi, F., & Ikejima, T. (2007). Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent. Acta Pharmacologica Sinica, 28, 803-810. (Pubitemid 46817427)
29. Shoshan-Barmatz, V., Keinan, N., & Zaid, H. (2008). Uncovering the role of VDAC in the regulation of cell life and death. Journal of Bioenergetics and Biomembranes, 40, 183-191.
30. Green, P. S., & Leeuwenburgh, C. (2002). Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. Biochimica et Biophysica Acta, 1588, 94-101.
31. Spallarossa, P., Garibaldi, S., Altieri, P., Fabbi, P., Manca, V., Nasti, S., et al. (2004). Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. Journal of Molecular and Cellular Cardiology, 37, 837-846. (Pubitemid 39222076)
32. Yu, X. Y., Geng, Y. J., Liang, J. L., Lin, Q. X., Lin, S. G., Zhang, S., et al. (2010). High levels of glucose induce apoptosis in car-diomyocyte via epigenetic regulation of the insulin-like growth factor receptor. Experimental Cell Research, 316, 2903-2909.
33. Watkins, S. J., Borthwick, G. M., & Arthur, H. M. (2010). The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In vitro cellular & developmental biology. Animal, 47(2), 125-131.
34. De Angelis, A., Piegari, E., Cappetta, D., Marino, L., Filippelli, A., Berrino, L. et al. (2009). Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation 121, 276-292.
35. Remiao, F., Carmo, H., Carvalho, F., & Bastos, M. L. (2001). Copper enhances isoproterenol toxicity in isolated rat cardio-myocytes: Effects on oxidative stress. Cardiovascular Toxicology, 1, 195-204. (Pubitemid 37013747)
36. Brodde, O. E. (1988). The functional importance of beta 1 and beta 2 adrenoceptors in the human heart. American Journal of Cardiology, 62, 24C-29C.
37. Communal, C., Singh, K., Sawyer, D. B., & Colucci, W. S. (1999). Opposing effects of beta(1)-and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: Role of a pertussis toxin-sensitive G protein. Circulation, 100, 2210-2212.
38. Li, J., Yan, B., Huo, Z., Liu, Y., Xu, J., Sun, Y., et al. (2010). Beta2-but not beta1-adrenoceptor activation modulates intra-cellular oxygen availability. Journal of Physiology, 588, 2987-2998.
39. El-Armouche, A., & Eschenhagen, T. (2009). Beta-adrenergic stimulation and myocardial function in the failing heart. Heart Failure Reviews, 14, 225-241.
40. Dessy, C., & Balligand, J. L. (2010). Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Advances in Pharmacology, 59, 135-163.
41. York, M., Scudamore, C., Brady, S., Chen, C., Wilson, S., Curtis, M., et al. (2007). Characterization of troponin responses in iso-proterenol-induced cardiac injury in the Hanover Wistar rat. Toxicologic Pathology, 35, 606-617.
42. Del Carlo, C. H., Pereira-Barretto, A. C., Cassaro-Strunz, C. M., Latorre Mdo, R., Oliveira Junior, M. T., & Ramires, J. A. (2009). Cardiac troponin T for risk stratification in decompensated chronic heart failure. Arquivos brasileiros de cardiologia, 92(5), 372-380, 389-397, 404-412.
43. Halestrap, A. P., McStay, G. P., & Clarke, S. J. (2002). The permeability transition pore complex: Another view. Biochimie, 84, 153-166.
44. Jacobson, J., & Duchen, M. R. (2002). Mitochondrial oxidative stress and cell death in astrocytes-requirement for stored Ca2? and sustained opening of the permeability transition pore. Journal of Cell Science, 115, 1175-1188. (Pubitemid 34272482)
45. Sharaf El Dein, O., Gallerne, C., Deniaud, A., Brenner, C., & Lemaire, C. (2009). Role of the permeability transition pore complex in lethal inter-organelle crosstalk. Front Biosci, 14, 3465-3482.
46. Biary, N., & Akar, F. G. (2010). A brighter side of ROS revealed by selective activation of beta-adrenergic receptor subtypes. Journal of Physiology, 588, 2973-2974.
47. Rong, Y., & Distelhorst, C. W. (2008). Bcl-2 protein family members: Versatile regulators of calcium signaling in cell survival and apoptosis. Annual Review of Physiology, 70, 73-91. (Pubitemid 351738172)
48. Fiedler, B., & Wollert, K. C. (2005). Targeting calcineurin and associated pathways in cardiac hypertrophy and failure. Expert Opinion on Therapeutic Targets, 9, 963-973. (Pubitemid 41488834)
49. Ullrich, V., Namgaladze, D., & Frein, D. (2003). Superoxide as inhibitor of calcineurin and mediator of redox regulation. Toxicology Letters, 139, 107-110. (Pubitemid 36298968)
50. Sayen, M. R., Gustafsson, A. B., Sussman, M. A., Molkentin, J. D., & Gottlieb, R. A. (2003). Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production. American Journal of Physiology. Cell Physiology, 284, C562-C570. (Pubitemid 36120094)
51. Aramburu, J., Heitman, J., & Crabtree, G. R. (2004). Calcineurin: A central controller of signalling in eukaryotes. EMBO Report, 5, 343-348.
52. De Windt, L. J., Lim, H. W., Taigen, T., Wencker, D., Condorelli, G., Dorn, G. W., 2nd, et al. (2000). Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. Circulation Research, 86, 255-263. (Pubitemid 30108817)
53. Lim, M. J., Seo, Y. H., Choi, K. J., Cho, C. H., Kim, B. S., Kim, Y. H., et al. (2007). Suppression of c-Src activity stimulates muscle differentiation via p38 MAPK activation. Archives of Biochemistry and Biophysics, 465, 197-208. (Pubitemid 47299087)
54. Zetser, A., Gredinger, E., & Bengal, E. (1999). p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. Journal of Biological Chemistry, 274, 5193-5200.
55. Wu, Z., Woodring, P. J., Bhakta, K. S., Tamura, K., Wen, F., Feramisco, J. R., et al. (2000). p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Molecular and Cellular Biology, 20, 3951-3964. (Pubitemid 30314494)
56. Tsang, M. Y., & Rabkin, S. W. (2009). p38 mitogen-activated protein kinase (MAPK) is activated by noradrenaline and serves a cardioprotective role, whereas adrenaline induces p38 MAPK dephosphorylation. Clinical and Experimental Pharmacology and Physiology, 36, e12-e19.
57. Clements, P., Brady, S., York, M., Berridge, B., Mikaelian, I., Nicklaus, R., et al. (2010). Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat. Toxicologic Pathology, 38, 703-714.
58. Feng, W., & Li, W. (2010). The study of ISO induced heart failure rat model. Experimental and Molecular Pathology, 88, 299-304.
59. Heather, L. C., Catchpole, A. F., Stuckey, D. J., Cole, M. A., Carr, C. A., & Clarke, K. (2009). Isoproterenol induces in vivo functional and metabolic abnormalities: similar to those found in the infarcted rat heart. Journal of Physiology and Pharmacology, 60, 31-39.
60. Slotkin, T. A., Lappi, S. E., & Seidler, F. J. (1995). Beta-adren-ergic control of c-fos expression in fetal and neonatal rat tissues: relationship to cell differentiation and teratogenesis. Toxicology and Applied Pharmacology, 133, 188-195.
61. Iwasaki, T., Takino, Y., & Suzuki, T. (1990). Effects of isopro-terenol on the developing heart in rats. Japanese Circulation Journal, 54, 109-116. (Pubitemid 20231047)